HL7 v2.3 Vocabulary
0.1.0 - ci-build

HL7 v2.3 Vocabulary, published by HL7/FO. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/frankoemig/hl7.v2.terminology.v23/ and changes regularly. See the Directory of published versions

## CodeSystem: Vaccines Administered (2.3 - 1.0.0) (Experimental)

Official URL: http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7 | Version: 1.0.0
Active as of 2026-01-27 | Computable Name: VaccinesAdministeredHL7
Other Identifiers: OID:2.16.840.1.113883.18.182
Copyright/Legal: HL7 Inc., 2026

Code system of codes specifying the administered vaccines, and used only in HL7 releases 2.3, 2.3.1, and 2.4 of the standard. This code system was superceded when the US Centers of Disease Control began publishing the codes directly; the code system to be used now is 2.16.840.1.113883.12.292 PH_VaccinesAdministeredCVX_CDC_NIP.

This Code system is referenced in the content logical definition of the following value sets:

- Hl7VSvaccinesAdministered

Properties

This code system defines the following properties for its concepts

Name | Code | URI | Type | Description
versionIntroduced | versionIntroduced | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#versionIntroduced | string | version when was this code introduced
versionDeprecated | versionDeprecated | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#versionDeprecated | string | version when was this code deprecated
status | status | http://hl7.org/fhir/concept-properties#status | code | A code that indicates the status of the concept. Typical values are active, experimental, deprecated, and retired
comment | comment | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#comment | string | A string that provides additional detail pertinent to the use or understanding of the concept
usage | usage | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#usage | string | usage notes for this code
modified | modified | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#modified | dateTime | date of last modification

Concepts

This case-sensitive code system `http://terminology.hl7.org/v2plusvocab/CodeSystem/vaccinesAdministeredHL7` defines the following codes:

Code | Display | Definition | versionIntroduced | usage
01 | DTP | DTP | 2.3 | Diphtheria-tetanus-pertussis
02 | OPV | OPV | 2.3 | Poliovirus vaccine, oral
03 | MMR | MMR | 2.3 | Measles-mumps-rubella
04 | M/R | M/R | 2.3 | Measles & rubella
05 | Measles | Measles | 2.3 | Measles
06 | Rubella | Rubella | 2.3 | Rubella
07 | Mumps | Mumps | 2.3 | Mumps
08 | Hep B - adolescent or pediatric | Hep B - adolescent or pediatric | 2.3 | Hepatitis B—adolescent or pediatric
09 | Td (Adult) | Td (Adult) | 2.3 | Tetanus-diphtheria
10 | IPV | IPV | 2.3 | Poliovirus vaccine, inactivated
11 | Pertussis | Pertussis | 2.3 | Pertussis
12 | Diphtheria antitoxin | Diphtheria antitoxin | 2.3 | Diphtheria antitoxin
13 | TIG | TIG | 2.3 | Tetanus immune globulin
14 | IG | IG | 2.3 | Immune globulin
15 | Influenza—split (incl. purified surface antigen) | Influenza—split (incl. purified surface antigen) | 2.3 | Influenza—split (incl. purified surface antigen)
16 | Influenza—whole | Influenza—whole | 2.3 | Influenza—whole
17 | Hib-unspecified | Hib-unspecified | 2.3 | Haemophilus influenzae type b conjugate—unspecified
18 | Rabies—intramuscular injection | Rabies—intramuscular injection | 2.3 | Rabies—intramuscular injection
19 | BCG | BCG | 2.3 | Bacillus of Calmette & Guerin
20 | DTaP | DTaP | 2.3 | Diphtheria-tetanus-acellular pertussis
21 | Varicella | Varicella | 2.3 | Varicella
22 | DTP-Hib | DTP-Hib | 2.3 | DTP-Haemophilus influenzae type b conjugate
23 | Plague | Plague | 2.3 | Plague
24 | Anthrax | Anthrax | 2.3 | Anthrax
25 | Typhoid—oral | Typhoid—oral | 2.3 | Typhoid—oral
26 | Cholera | Cholera | 2.3 | Cholera
27 | Botulinum antitoxin | Botulinum antitoxin | 2.3 | Botulinum antitoxin
28 | DT(pediatric) | DT(pediatric) | 2.3 | Diphtheria & tetanus toxoids (pediatric)
29 | CMVIG | CMVIG | 2.3 | Cytomegalovirus immune globulin, intravenous
30 | HBIG | HBIG | 2.3 | Hepatitis B immune globulin
31 | Hep A - pediatric | Hep A - pediatric | 2.3 | Hepatitis A
32 | Meningococcal | Meningococcal | 2.3 | Meningococcal
33 | Pneumococcal | Pneumococcal | 2.3 | Pneumococcal
34 | RIG | RIG | 2.3 | Rabies immune globulin
35 | Tetanus toxoid | Tetanus toxoid | 2.3 | Tetanus toxoid
36 | VZIG | VZIG | 2.3 | Varicella zoster immune globulin
37 | Yellow fever | Yellow fever | 2.3 | Yellow fever
38 | Rubella/Mumps | Rubella/Mumps | 2.3 | Rubella & Mumps
39 | Japanese encephalitis | Japanese encephalitis | 2.3 | Japanese encephalitis
40 | Rabies-intradermal injection | Rabies—intradermal injection | 2.3 | Rabies—intradermal injection
41 | Typhoid-parenteral | Typhoid-parenteral | 2.3 | Typhoid—parenteral
42 | Hep B- adolescent/high risk infant | Hep B- adolescent/high risk infant | 2.3 | Hepatitis B—adolescent/high risk infant
43 | Hep B-adult | Hep B-adult | 2.3 | Hepatitis B—adult
44 | Hep B-dialysis | Hep B-dialysis | 2.3 | Hepatitis B—dialysis
45 | Hep B-other or unspecified | Hep B-other or unspecified | 2.3 | Hepatitis B—other or unspecified
46 | Hib-PRP-D | Hib-PRP-D | 2.3 | Haemophilus influenzae type b conjugate—PRP-D
47 | Hib-HbOC | Hib-HbOC | 2.3 | Haemophilus influenzae type b conjugate—HbOC
48 | Hib-PRP-T | Hib-PRP-T | 2.3 | Haemophilus influenzae type b conjugate—PRP-T
49 | Hib-PRP-OMP | Hib-PRP-OMP | 2.3 | Haemophilus influenzae type b conjugate—PRP-OMP
50 | Dtap-Hib | Dtap-Hib | 2.3 | DTaP - Haemophilus influenzae type b conjugate
51 | Hib-Hep B | Hib-Hep B | 2.3 | Haemophilus influenzae type b conjugate - Heb-B
52 | Hep A - adult | Hep A - adult | 2.3 | Hepatitis A